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Purpose:  Nitric oxide (NO) has been known as an important regulator of osteoblasts and periodontal ligament cell activity. 
This study was performed to investigate the relationship between NO-mediated cell death of human periodontal ligament fi-
broblasts (PDLFs) and N-methyl-D-aspartic acid (NMDA) receptor antagonist (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cy-
clohepten-5, 10-imine hydrogen maleate (MK801). 
Methods:  Human PDLFs were treated with various concentrations (0 to 4 mM) of sodium nitroprusside (SNP) with or with-
out 200 μM MK801 in culture media for 16 hours and the cell medium was then removed and replaced by fresh medium con-
taining MTS reagent for cell proliferation assay. Western blot analysis was performed to investigate the effects of SNP on the 
expression of Bax, cytochrome c, and caspase-3 proteins. The differences for each value among the sample groups were com-
pared using analysis of variance with 95% confidence intervals.
Results:  In the case of SNP treatment, as a NO donor, cell viability was significantly decreased in a concentration-dependent 
manner. In addition, a synergistic effect was shown when both SNP and NMDA receptor antagonist was added to the medi-
um. SNP treated PDLFs exhibited a round shape in culture conditions and were dramatically reduced in cell number. SNP 
treatment also increased levels of apoptotic marker protein, such as Bax and cytochrome c, and reduced caspase-3 in PDLFs. 
Mitogen-activated protein kinase signaling was activated by treatment of SNP and NMDA receptor antagonist. 
Conclusions: These results suggest that excessive production of NO may induce apoptosis and that NMDA receptor may mod-
ulate NO-induced apoptosis in PDLFs.
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INTRODUCTION
Nitric oxide (NO), a free radical synthesized from L-argi-
nine by NO synthases (NOS), can modulate various tissue 
and cell activities, including vasodilation, neurotransmission, 
immune responses, and death control [1,2]. NO is also involved 
in the regulation of bone metabolism through the several bi-
ological process [3]. Bone forming osteoblasts constitutively 
produce a small amount of NO which regulates proliferation 
and differentiation of osteoblasts [4,5]. Overproduction of 
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NO, which is stimulated by inflammatory cytokines or me-
chanical stress of osteoblasts, may lead to cell damage and 
initiate and regulate apoptosis [4,6,7]. In inflammation-in-
duced osteoporosis, elevated levels of NO have been shown 
to cause apoptosis and to increase bone-resorption by osteo-
clasts, resulting in decreased bone mineral density [8].
In the central nervous system, NO production is closely as-
sociated with N-methyl-D-aspartic acid (NMDA) receptors 
[9]. NMDA receptors, as glutamate receptors residing in pre-
synaptic and postsynaptic neurons, have been known to con-
trol synaptic plasticity and memory formation in the central 
nervous system [10]. Upon stimulation of NMDA receptors 
by an external signal, Ca
2+ enters the cell through the activat-
ed ionotropic NMDA receptor and then NO is produced by 
NOS which translocates to the membrane and is activated by 
Ca
2+ [11]. An increase in NO induces excitotoxic cell death or 
apoptotic events in afflicted neurons.
Previous studies have revealed that glutamate NMDA re-
ceptors in osteoblasts may be involved in regulation of bone 
formation [12,13]. Recently, we have also reported that NMDA 
receptors are involved in periodontal ligament fibroblast 
(PDLF) differentiation but not their proliferation [14]. PDL 
cells form the connective tissue between the tooth cemen-
tum and alveolar bone to anchor teeth and maintain struc-
tural integrity. In addition, PDLFs have the potential to dif-
ferentiate into cementoblasts and osteoblasts needed for ce-
mentum and alveolar bone formation, respectively [15-17]. 
Mechanical stress has been shown to promote an increase 
in NO production in cultured human PDL cells [18]. Consti-
tutive NO production arising from chewing or other mechan-
ical-stress of teeth may play several roles in periodontal tis-
sues, such as serving to maintain structural integrity of PDL 
[19] and regulating PDL response to various stimuli like pro-
inflammatory cytokines, mechanical strain, and sex hormones 
[6,20,21]. However, excessively produced NO may lead to cell 
damage in periodontal tissues similar to that in endothelial 
cells and osteoblasts [22,23]. For example, lipoplysaccharide 
(LPS)-induced nitrite synthesis in PDLFs and osteoblasts led 
to cell apoptosis and increased pro-apoptotic responses to 
cytokines [24,25]. This has been shown in the cell types such 
as human monocytes, endothelial cells, macrophages, and 
gingival fibroblasts, which produce inflammatory cytokines 
via stimuli of bacteria or bacterial components like LPS [26].
 However, the function of NMDA receptor in NO-mediat-
ed PDLF cell damage has not been well characterized. We in-
vestigated the relationship between the effect of excessively 
produced NO using sodium nitroprusside (SNP) and NMDA 
receptor antagonist.
MATERIALS AND METHODS
Chemicals and antibodies
(+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 
10-imine hydrogen maleate (MK801) and SNP were pur-
chased from Sigma Aldrich (St. Louis, MO, USA). 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sul-
fophenyl)-2H-tetrazolium, inner salt (MTS) was purchased 
from Promega (Madison, WI, USA ). Cell culture reagents 
were obtained from Hyclone (Logan, UT, USA) and Gibco 
(Paisley, Scotland). Protease inhibitor cocktail was purchased 
from Roche (Rotkreuz, Switzerland). Primary antibodies of 
caspase-3, Bax, cytochrome c, c-Jun N-terminal kinase/stress-
activated protein kinase (JNK/SARK), mitogen-activated pro-
tein kinases (p38) and anti-rabbit, anti-mouse second anti-
bodies were obtained from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). Anti-phosphorylated extracellular signal-reg-
ulated kinases (pERK), ERK rabbit polyclonal antibodies were 
prepared by Cell Signaling Technology (Beverly, MA, USA). 
β-actin mouse monoclonal antibody was purchased from 
Sigma Aldrich.
Cell culture and chemical treatment
Human PDLFs were purchased from ScienCell (San Diego, 
CA, USA). They were cultured in α-MEM supplemented with 
10% fetal bovine serum, 100 U/mL penicillin and 100 μg/mL 
streptomycin at 37°C in a 5% CO2 humidified atmosphere. 
SNP was dissolved in phosphate buffered saline (PBS) buffer 
to 1 M as stock solution, stored frozen at -20°C and protected 
from light for use in related experiments. PDLFs were treated 
with various concentrations (0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 mM) 
of SNP with or without 200 μM MK801 in culture media for 
16 hours and PDLF morphologies were observed and photo-
graphed. All of the media were changed every 3 days.
Cell proliferation assay
After the cells were treated with SNP at the various concen-
trations for 16 hours, the cell medium was removed and then 
replaced by fresh medium containing MTS reagent. The cells 
were incubated at 37°C in a 5% CO2 for 3 hours, and then the 
absorbance at 490 nm was measured on a microplate reader 
(Molecular Devices, Sunnyvale, CA, USA). 
Western blot analysis
Human PDLFs were washed with PBS and collected in ra-
dioimmunoprecipitation assay buffer (150 mM sodium chlo-
ride, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate [SDS], 50 mM Tris-HCl, pH 7.5, and 2 mM eth-
ylenediaminetetraacetic acid) with protease inhibitor cocktail 
(Roche, Rotkreuz, Switzerland). Equal amounts of proteins Journal of Periodontal
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were separated by SDS-polyacrylamide gel electrophoresis 
and transferred to polyvinylidine fluoride membrane. The 
membrane was incubated with blocking buffer containing 
5% skim milk in tris buffered saline for 2 hours. After block-
ing, the membranes were incubated for 2 hours with primary 
antibody, 1:1,000 anti-pERK, anti-ERK, anti-caspase-3 rabbit 
polyclonal antibodies, and anti-Bax, anti-cytochrome c, anti-
β-actin mouse monoclonal antibodies, followed by incuba-
tion for 1 hour with 1:5,000 anti-rabbit and anti-mouse sec-
ondary antibodies, respectively. The membrane was detected 
with the aid of electrochemiluminescence detection reagents 
(Takara, Kyoto, Japan) using a fluorescence imaging system 
(Fuji Film, Tokyo, Japan). 
Data analysis
A statistical software package (SPSS Inc., Chicago, IL, USA) 
was used to evaluate the data on cell proliferation. The differ-
ences for each value among the sample groups were com-
pared using analysis of variance. The statistical significance 
of the results was analyzed using 95% confidence intervals. 
RESULTS
Effect of NO and NMDA receptor antagonist on the viabil-
ity in PDLFs
To determine the effect of SNP on the PDLFs, we first ob-
served morphological changes. PDLF morphologies were 
observed and photographed following treatments of 0 to 4 
mM SNP with or without 200 μM MK801, the NMDA recep-
tor antagonist, for 16 hours. There was alteration of PDLF cell 
morphology in a SNP concentration-dependent manner. 
The 3 mM SNP treated PDLFs led to a dramatic reduction in 
the numbers of flat, spread, and spindle-shaped fibroblasts 
and loss of cell-cell contact, and increased cellular debris from 
apparently dead/dying cells (Fig. 1A). The PDLF morpholo-
gies were largely unaltered when they were cultured with 0 
to 2 mM SNP. Interestingly, the PDLF morphology and via-
bility were more sensitive to SNP in the presence of MK801, 
the blocker of NMDA receptors; the rounded and floating 
cells, and large loss of flat and spread PDLFs were observed 
at 2 mM SNP (Fig. 1A). We determined cell viability by MTS 
assay after SNP and MK801 exposure. Exposure of PDLFs to 
0 and 0.5 mM SNP for 16 hours did not affect cell viability. In 
the 2.5 mM SNP treated PDLFs, significantly decreased opti-
cal density (A490) was determined by MTS assay, and in the 
presence of MK801, 1 mM SNP treated PDLFs showed simi-
larly significant reduction compared to the untreated control 
(Fig. 1B), suggesting that PDLF viability is sensitive to NO and 
MK801. 
Effects of NO and NMDA antagonist on the expression of 
apoptotic proteins
Fig. 2 shows the effects of SNP on Bax, cytochrome c, and 
caspase-3 proteins. Administration of SNP in PDLFs increased 
4 mM 3 mM 2 mM 1 mM +SNP 0 mM
Control
+MK801
A
Figure 1.  Effect of sodium nitroprusside (SNP) on the viability of 
periodontal ligament fibroblasts (PDLFs). PDLFs showed morpho-
logical changes following treatment with SNP and SNP+200 μM 
(+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-im-
ine hydrogen maleate (MK801) for 16 hours (A). PDLFs were treated 
with SNP at indicated concentrations for 16 hours and the cell viabil-
ity was determined by MTS assay (B). Magnification ×100. 
a)Indi-
cates significantly different from non-treated cells (P<0.05). OD: 
optical density.
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Bax and cytochrome c production. However caspase-3 pro-
tein was decreased. Bax protein production was increased in 
2 mM SNP treated PDLFs, and was highly expressed at 1 mM 
SNP treated cells in the presence of MK801. Cytochrome c 
protein represented the high expression in 2 mM SNP treat-
ed PDLFs. In MK801 treated PDLFs showed that cytochrome 
c was highly expressed at 1 mM SNP treatment. Caspase-3 
protein was decreased in 3 mM SNP treated PDLFs and 2 
mM SNP treated PDLFs in the presence of MK801. These re-
sults suggest that PDLFs reacted more sensitively in the 
presence of MK801 compared to the group treated with SNP 
alone. 
Effects of NO and NMDA antagonist on the expression of 
apoptotic proteins and MAPK pathway proteins
SNP treated PDLFs increased the phosphorylation of mito-
gen-activated protein kinase (MAPK) pathway proteins such 
as JNK/SARK, ERK, and p38 (Fig. 3). Western blot results re-
vealed that phosphorylation of JNK/SARK and ERK proteins 
were induced from 3 mM SNP treated PDLFs. In the presence 
of MK801, increased phosphorylation of these proteins was 
shown in 2 mM SNP treated PDLFs. Phosphorylation of p38 
was detected in 4 mM SNP treated PDLFs and revealed with 
3 mM SNP in the presence of MK801. Notably, pERK was 
significantly increased in the presence of SNP and MK801.
DISCUSSION
Many of the pathogenic effects of bacteria in periodontitis 
involving alveolar bone destruction are mediated by bacterial 
products including endotoxin or LPS [27,28]. LPS can directly 
induce cell death or apoptosis in many cell types, and by stim-
ulating NO production in macrophages, epithelial cells, and 
fibroblasts [29-31]. The production of high levels of NO in 
various cells is associated with autocytotoxicity, suppression 
of carcinogenesis, and inhibition of metastasis that result 
partially from induction of apoptosis [32]. 
In central neurons, NO is produced by elevated cytosolic 
Ca
2+ which constitutively activates neuronal NOS (nNOS) via 
the activation of glutamate NMDA receptors [9]. There are 
two NOS subtypes: inducible NOS (iNOS) found in fibro-
blasts and macrophages and endothelial NOS (eNOS) in blood 
vessel walls [33]. PDL cells express both eNOS and iNOS, and 
NO products by eNOS, and iNOS modulates the function of 
PDL cells [19] and by occlusal stimuli in the rat PDL promotes 
PDL healing in transplanted teeth [34]. In this study we fo-
cused on the relation of NO and NMDA receptors in PDLFs. 
NO released by SNP, an extracellular NO donor, has similar 
cytotoxic effects on PDLFs to induction of intracellular NO 
which is produced by NOS. A high level of NO induces oxi-
dative stress in cells that may lead to apoptosis accompanied 
by changes in gene expression, and cell dysfunction and 
damage. As shown in Fig. 1, SNP treated PDLFs are associat-
ed with cell viability as evidenced by changes in their mor-
phology into shrunken and round from spindle-shaped, and 
by the decrease in cell number and reduction in response to 
MTS assay. When PDLFs were treated with NMDA receptor 
antagonist, cell death of PDLFs was promoted at a lower con-
centration than only administration of SNP. In addition, our 
results showed that the oxidative stress by SNP-induced NO 
increased expression of apoptotic marker proteins such as 
Bax and cytochrome c. Interestingly, MK801 treatment of 
SNP stimulated PDLFs further enhanced the apoptotic re-
sponses of these cells in morphology and apoptosis marker 
protein expression than SNP treatment alone. Our results 
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Figure 2.  Sodium nitroprusside (SNP) altered the expression of 
apoptosis marker proteins. Periodontal ligament fibroblasts were 
treated with SNP and (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]
cyclohepten-5, 10-imine hydrogen maleate (MK801) for 16 hours. 
The cell lysates were performed to Western blot analysis using anti-
Bax, anti-cytochrome c, anti-caspase-3, and anti-β-actin antibodies. 
β-actin was used as internal control.
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Figure 3.  Sodium nitroprusside (SNP) induced phosphorylation of 
mitogen-activated protein kinases in periodontal ligament fibro-
blasts (PDLFs). PDLFs were treated with SNP and (+)-5-methyl-10, 
11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine hydrogen ma-
leate (MK801) for 16 hours. The cell lysates were performed to West-
ern blot analysis using anti-c-Jun N-terminal kinase/stress-activat-
ed protein kinase (JNK/SARK), anti-extracellular-signal-regulated 
kinase (ERK), anti-mitogen-activated protein kinases (p38), anti-
phosphorylated JNK/SARK, anti-phosphorylated ERK or anti-phos-
phorylated p38 antibodies. Journal of Periodontal
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suggest that SNP, as a nitric donor, promotes apoptotic pro-
tein-induced PDLF cell death.
De novo synthesis of Bax protein by SNP has been shown 
to be proapoptotic in NO-induced osteoblast death [35], sug-
gesting that increased Bax protein levels may be a critical 
trigger of apoptosis induced by oxidative stress in osteoblasts 
[36]. Cytochrome c is another well-known marker protein of 
apoptosis that may be released from mitochondria to the cy-
toplasm in osteoblasts under oxidative stress and associated 
depolarization of the mitochondrial membrane potential [37]. 
Decreased levels of caspase-3 expression in SNP treated 
PDLFs are also consistent with conversion and activation 
from the inactive form of caspase-3, which is specifically la-
beled as anti-caspase-3 antibody in the immunoblot analysis 
shown in Fig. 2. Activation of caspase-3 can cause the diges-
tion of key cellular proteins and induce DNA fragmentation 
and cell apoptosis [38,39]. Possibly, similar proapoptotic alter-
ations in Bax levels, cytochrome c-mediated activation of 
caspase-3 activity, and DNA fragmentation may have oc-
curred in PDLFs treated with SNP in our study.
In most cells, NO-mediated apoptosis typically involves ac-
tivation by phosphorylation of the JNK/SARK, ERK, and p38 
groups of MAPKs [40]. We monitored the phosphorylation of 
ERK, p38, and JNK following treatment with SNP and SNP/
MK801 to determine whether these kinases were involved in 
the signaling pathway of NO-mediated apoptosis in PDLFs. 
In NO induced PDLFs, phosphorylation of JNK/SARK, ERK 
and p38 was increased compared to the control PDLFs. In 
PDLFs treated with SNP and MK801, the phosphorylation of 
the MAPK panel occurred at lower concentrations of SNP that 
also produced morphologic and biochemical differences as 
shown in Fig. 1. Overall, these results indicate that in PDLFs, 
NO overproduction may induce an apoptosis signal via the 
MAPK pathway, and suggest that activated glutamate NMDA 
receptors in PDLFs may inhibit cell death and apoptosis, which 
are induced by conditions that stimulate excessive NO pro-
duction, such as periodontal bacterial infections. 
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